Regimens Comparison for Breast Cancers of Positive Lymph Nodes
NCT01134523
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Epirubicin, CTX, Paclitaxel
DRUG:
Epirubicin, Paclitaxel
Sponsor
Chinese Academy of Medical Sciences